RNA in disease

Información del proyecto

RiboMed

Identificador del acuerdo de subvención: 857119

DOI

10.3030/857119

Proyecto cerrado

Fecha de la firma de la CE 9 Julio 2019

Fecha de inicio 1 Septiembre 2019

Fecha de finalización 28 Febrero 2023

Financiado con arreglo a

• Twinning of research institutions

Coste total

€ 799 750,00

Aportación de la UE

€ 799 750,00

Coordinado por

FUNDACAO GIMM - GULBENKIAN INSTITUTE FOR MOLECULAR MEDICINE
Portugal

CORDIS proporciona enlaces a los documentos públicos y las publicaciones de los proyectos de los programas marco HORIZONTE.

Los enlaces a los documentos y las publicaciones de los proyectos del Séptimo Programa Marco, así como los enlaces a algunos tipos de resultados específicos, como conjuntos de datos y «software», se obtienen dinámicamente de OpenAIRE .

Resultado final

Documents, reports (7)

First Summer School

The organisation of the First RiboMed summer school will be reported

"""Science gallery in the street"" campaign"

The organisation of a science outreach event will bereported

International conference on RNA in disease

The organisation of an important international conference on RNA in disease will be reported

Development of communication material

An initial set of communication material will be developed as to increase awareness of biomedical research in general, and iMM researchers in particular.

First Annual Project Meeting

The Consortium will together with the Scientific Advisory Board discuss the achievements and suggest alterations if necessary and this meeting will be reported

Widening KPI: Evolution of the publications in high impact journals in the RiboMed research field

Widening KPI: all the publications of iMM in high impact journals in the RiboMed research field published in 3 years prior to the start of RiboMed will be inserted in the GMS PP, and a 1-page statement report will be submitted.

Second Summer School

The organisation of the Second RiboMed Summer School will be reported

Publicaciones

Peer reviewed articles (15)

Silencing of the lncRNA Zeb2-NAT facilitates reprogramming of aged fibroblastos and safegards stem cell pluripotency

Autores: Bernardes de Jesus B, Matinho SP, Barros S, Sousa-Franco A, Alves-Vale C, Carvalho T, Carmo-Fonseca M
Publicado en: Nature Communications, 2018, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-017-01921-6

Short(16-mer) locked nucleic acid splice-switching oligonucleotides restore dystrophin production in Duchenne Muscular Dystrophy myotubes

Autores: Pires VB, Simões R, Mamchaoui K, Carvalho C, Carmo-Fonseca M.
Publicado en: PLOS ONE, 2017, ISSN 1932-6203
Editor: Public Library of Science
DOI: 10.1371/journal.pone.0181065

Deep intronic mutations and human disease.

Autores: Vaz-Drago R, Custódio N, Carmo-Fonseca M.
Publicado en: Human Genetics, Edición 136/9, 2017, ISSN 0340-6717
Editor: Springer Verlag
DOI: 10.1007/s00439-017-1809-4

Reduced Lamin A/C Does Not Facilitate Cancer Cell Transendothelial Migration but Compromises Lung Metastasis.

Autores: Francesco Roncato; Ofer Regev; Sara W. Feigelson; Sandeep Kumar Yadav; Lukasz Kaczmarczyk; Nehora Levi; Diana Drago-Garcia; Samuel Ovadia; Marina Kizner; Yoseph Addadi; João C. Sabino; Yossi Ovadya; Sérgio F. de Almeida; Ester Feldmesser; Gabi Gerlitz; Ronen Alon
Publicado en: Volume 13, Edición 3, 2021, ISSN 2078-2489
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/cancers13102383

Design principles for pluripotent stem cell-derived organoid engineering

Autores: Silva TP, Cotovio JP, Bekman E, Carmo-Fonseca M, Cabral JMS, Fernandes TG
Publicado en: Stem Cells International, 2019, ISSN 1687-9678
Editor: Stem Cells International
DOI: 10.1155/2019/4508470

Pharmacological inhibition of the spliceosome subunit SF3b triggers EJC-independent NMD

Autores: Carvalho T, Martins S, Rino J, Marinho S, Carmo-Fonseca M.
Publicado en: Journal of Cell Science, Edición 130/9, 2017, ISSN 0021-9533
Editor: The Company of Biologists Ltd.
DOI: 10.1242/jcs.202200

Transcription and splicing dynamics during early Drosophila development

Autores: Prudêncio P, Rebelo K, Savisaar R, Martinho RG, Carmo-Fonseca M
Publicado en: RNA, 2021, ISSN 1355-8382
Editor: Cold Spring Harbor Laboratory Press
DOI: 10.1261/rna.078933.121

RNA Splicing Defects in Hypertrophic Cardiomyopathy: Implications for Diagnosis and Therapy

Autores: Marta Ribeiro, Marta Furtado, Sandra Martins, Teresa Carvalho, Maria Carmo-Fonseca
Publicado en: International Journal of Molecular Sciences, Edición 21/4, 2020, Página(s) 1329, ISSN 1422-0067
Editor: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/ijms21041329

Epigenetic reprogramming by TET enzymes impacts co-transcriptional R-loops

Autores: João C. Sabino, Madalena R. de Almeida, Patrícia L.Abreu, Ana M. Ferreira, Marco M Domingues, Nuno C Santos, Claus Azzalin, Ana Rita Grosso, Sérgio Fernandes de Almeida
Publicado en: Elife, 2022, ISSN 2050-084X
Editor: eLife Sciences Publications
DOI: 10.7554/elife.69476

POINT technology illuminates the processing of polymerase-associated intact nascent transcripts

Autores: Rui Sousa-Luís, Gwendal Dujardin, Inna Zukher, Hiroshi Kimura, Carika Weldon, Maria Carmo-Fonseca, Nick J. Proudfoot, Takayuki Nojima
Publicado en: Molecular Cell, 2021, ISSN 1097-2765
Editor: Cell Press
DOI: 10.1016/j.molcel.2021.02.034

Whole gene sequencing identifies deep-intronic variants with potential functional impact in patients with hypertrophic cardiomyopathy

Autores: Mendes de Almeida R, Tavares J, Martins S, Carvalho T, Enguita FJ, Brito D, Carmo-Fonseca M, Lopes LR.
Publicado en: Plos One, Edición 12/8, 2017, ISSN 1932-6203
Editor: Public Library of Science
DOI: 10.1371/journal.pone.0182946

TERRA transcription destabilizes telomere integrity to initiate break-induced replication in human ALT cells

Autores: Silva B, Arora R, Bione S, Azzalin CM
Publicado en: Nature Communications, 2021, ISSN 2041-1723
Editor: Nature Publishing Group
DOI: 10.1038/s41467-021-24097-6

RNA Polymerase II phosphorylated on CTD Serine 5 interacts with the spliceosome during co-transcriptional splicing

Autores: Nojima T, Rebelo K, Gomes T, Grosso AR, Proudfoot NJ, Carmo-Fonseca M
Publicado en: Molecular Cell, Edición 72/2, 2018, ISSN 1097-2765
Editor: Cell Press
DOI: 10.1016/j.molcel.2018.09.004

Distinctive patterns of transcription and RNA processing for human lincRNAs

Autores: Schlackow M, Nojima T, Gomes T, Dhir A, Carmo-Fonseca M, Proudfoot NJ
Publicado en: Molecular Cell, Edición 65/1, 2017, ISSN 1097-2765
Editor: Cell Press
DOI: 10.1016/j.molcel.2016.11.029

Live-Cell Imaging of Transcriptional Activity at DNA Double-Strand Breaks.

Autores: Madalena R. de Almeida; Eduardo Gameiro; Sérgio F. de Almeida; Robert M. Martin
Publicado en: reponame:Repositório Científico de Acesso Aberto de Portugal, Edición 1, 2021, ISSN 1940-087X
Editor: MYJoVE Corporation
DOI: 10.3791/62968

Other (2)

betAS: intuitive analysis and visualisation of differential alternative splicing using beta distributions (pre-print)

Autores: Mariana Ascensao-Ferreira, Nuno Saraiva-Agostinho, Nuno L Barbosa-Morais
Publicado en: 2022
Editor: biorxiv
DOI: 10.1101/2022.12.26.521935

voyAGEr: free web interface for the analysis of age-related gene expression alterations in human tissues (pre-print)

Autores: Arthur L Schneider, Nuno Saraiva-Agostinho, Nuno L Barbosa-Morais
Publicado en: 2022
Editor: Biorxiv
DOI: 10.1101/2022.12.22.521681

Book chapters (1)

Quantitative image analysis of single-molecule mRNA dynamics in living cells

Autores: Rino J, de Jesus AC, Carmo-Fonseca M
Publicado en: Light Microscopy - Methods and Protocols, Edición 1563, 2017
Editor: Methods in Molecular Biology
DOI: 10.1007/978-1-4939-6810-7_15

Derechos de propiedad intelectual

Patent (3)

TREATMENT OF ALT CANCERS

Número de solicitud/publicación: 20 20050021
Fecha: 2020-05-23
Solicitante(s): INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

METHODS OF TREATMENT OF CANCER ASSOCIATED WITH CENTROSOME AMPLIFICATION

Número de solicitud/publicación: 20 19050045
Fecha: 2019-12-20
Solicitante(s): INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES

RANK PATHWAY INHIBITORS IN COMBINATION WITH CDK INHIBITORS

Número de solicitud/publicación: 20 20050017
Fecha: 2020-04-24
Solicitante(s): INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES